| Biomarker ID | 1535 |
| PMID | 25190021 |
| Year | 2014 |
| Biomarker | miRNA-221 |
| Biomarker Basis | Expression Based |
| Biomolecule | miRNA |
| Source | Serum |
| Subjects | Humans |
| Regulation | Upregulated in PCa( BPH: 1.2 ± 2.5; PCa: 6.9±4.6) |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathway include: homophilic cell adhesion via plasma membrane adhesion molecules; transcription by RNA polymerase II; regulation of transcription by RNA polymerase II; DNA binding; synapse |
| Experiment | Prostata Cancer Vs Benign prostatic hyperplasia |
| Type of Biomarker | Diagnostic |
| Cohort | 20 patients were enrolled in the study. 10 of them had Prostate Cancer and 10 had Benign prostatic hyperplasia (BPH) |
| Senstivity | 80% |
| Specificity | 80% |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p=0.004 |
| Method Used | qRT-PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |